NRIX Nurix Therapeutics, Inc. - Common stock
$15,92
Prix · Mai 20, 2026
Données fondamentales au Avr 8, 2026
Fourchette 52 semaines
$8–$22
54% of range
Note des analystes
BUY
23 analysts
Objectif de cours
$30
+90% upside
P/E (TTM)
-5.8
ROE
-53.6%
Marge nette
-314.9%
NRIX Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$15.91
Capitalisation Boursière
$1.80B
P/E (TTM)
-5.8
BPA (TTM)
$-3.05
Revenus (TTM)
$84M
Rendement div.
—
ROE
-53.6%
Dette/Capitaux propres
—
Fourchette 52 semaines
$8 – $22
NRIX Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$84M
2019-11-30
→
2025-11-30
BPA
$-3.05
2021-11-30
→
2025-11-30
Flux de trésorerie libre
$-263M
2020-11-30
→
2025-11-30
Marges
-314.9%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
NRIX
Médiane des pairs
P/E (TTM)
-5.8
—
P/S (TTM)
21.4
45.5
P/B
3.3
4.8
Price / FCF (Cours / FCF)
-6.8
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
NRIX
Médiane des pairs
Operating Margin (Marge d'exploitation)
-340.2%
—
Net Profit Margin (Marge nette)
-314.9%
-237.1%
ROA
-39.0%
-41.6%
ROE
-53.6%
-55.3%
ROIC
-53.2%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
NRIX
Médiane des pairs
Current Ratio (Ratio de liquidité)
7.0
5.7
Quick Ratio (Ratio de liquidité réduite)
2.9
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
NRIX
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
53.9%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
29.5%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
36.4%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
NRIX
Médiane des pairs
NRIX Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
23 analystes
- Achat fort 8 34,8%
- Achat 14 60,9%
- Conserver 1 4,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
17 analystes · 2026-05-19
Médiane
$30.00
← En dessous de tous les objectifs
$15.91
Bas
$23.00
Haut
$41.00
Objectif médian
$30.00
+88,5%
Objectif moyen
$30.18
+89,6%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.04%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.79 | $-0.77 | -0.02% |
| 31 décembre 2025 | $-0.82 | $-0.89 | 0.07% |
| 30 septembre 2025 | $-1.03 | $-0.86 | -0.17% |
| 30 juin 2025 | $-0.52 | $-0.74 | 0.22% |
| 31 mars 2025 | $-0.67 | $-0.78 | 0.11% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
| ANAB | — | -105.4 | 157.0% | — | — | — |
| SION | $1.84B | -21.9 | — | — | -23.4% | — |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| GENB | — | — | — | — | — | — |
| CAPR | $1.66B | -12.8 | -11.6% | — | -51.1% | — |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| SLS | $577M | -15.1 | — | — | -55.4% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $84M | $55M | $77M | $39M | $30M | $18M | $31M | |
| R&D Expense | $317M | $222M | $189M | $184M | $116M | $66M | $45M | |
| SG&A Expense | $53M | $46M | $43M | $38M | $31M | $16M | $8M | |
| Operating Expenses | $370M | $268M | $232M | $222M | $148M | $83M | $53M | |
| Operating Income | $-286M | $-213M | $-155M | $-184M | $-118M | $-65M | $-22M | |
| Pretax Income | $-264M | $-193M | $-144M | $-180M | $-117M | $-64M | $-21M | |
| Income Tax | $760.0K | $270.0K | $0 | $0 | $131.0K | $-21M | $239.0K | |
| Net Income | $-264M | $-194M | $-144M | $-180M | $-117M | $-43M | $-22M | |
| EPS (Basic) | $-3.05 | $-2.88 | $-2.65 | $-3.71 | $-2.73 | · | · | |
| EPS (Diluted) | $-3.05 | $-2.88 | $-2.65 | $-3.71 | $-2.73 | · | · | |
| Shares (Basic) | 86,666,907 | 67,120,266 | 54,337,901 | 48,607,990 | 42,895,383 | · | · | |
| Shares (Diluted) | 86,666,907 | 67,120,266 | 54,337,901 | 48,607,990 | 42,895,383 | · | · | |
| EBITDA | $-286M | $-213M | $-155M | $-184M | $-118M | $-65M | · |
Bilan 21
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $247M | $110M | $55M | $64M | $81M | $119M | $35M | |
| Short-term Investments | · | · | · | $245M | $215M | $162M | $3M | |
| Receivables | · | $0 | · | $0 | $6M | · | · | |
| Prepaid Expense | $14M | $10M | $8M | $9M | $9M | $6M | $2M | |
| Current Assets | $607M | $619M | $296M | $318M | $311M | $298M | $39M | |
| PP&E (Net) | $22M | $18M | $17M | $17M | $11M | $7M | $4M | |
| PP&E (Gross) | $60M | $52M | $43M | $37M | $26M | $20M | $15M | |
| Accum. Depreciation | $38M | $35M | $26M | $20M | $15M | $13M | $11M | |
| Other Non-current Assets | $7M | $3M | $4M | $4M | $3M | $177.0K | $147.0K | |
| Total Assets | $688M | $669M | $356M | $417M | $477M | $396M | $44M | |
| Accounts Payable | $11M | $11M | $6M | $5M | $7M | $3M | $2M | |
| Current Liabilities | $86M | $96M | $87M | $71M | $66M | $45M | $16M | |
| Capital Leases | $53M | $20M | $23M | $6M | $9M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $850.0K | $2M | |
| Total Liabilities | $149M | $142M | $155M | $113M | $134M | $106M | $54M | |
| Common Stock | $102.0K | $76.0K | $49.0K | $47.0K | $45.0K | $39.0K | $4.0K | |
| Retained Earnings | $-1.00B | $-739M | $-545M | $-401M | $-221M | $-104M | $-60M | |
| AOCI | $105.0K | $150.0K | $-655.0K | $-4M | $-608.0K | $87.0K | $-2.0K | |
| Stockholders' Equity | $539M | $527M | $200M | $304M | $342M | $290M | $-58M | |
| Liabilities + Equity | $688M | $669M | $356M | $417M | $477M | $396M | $44M | |
| Shares Outstanding | 101,807,484 | 75,870,718 | 48,718,552 | 47,172,299 | 44,664,371 | 38,864,872 | 3,595,334 |
Flux de trésorerie 11
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $9M | $8M | $5M | $3M | $2M | $2M | |
| Stock-based Comp | $38M | $34M | $34M | $28M | $16M | $4M | $510.0K | |
| Operating Cash Flow | $-249M | $-173M | $-81M | $-160M | $-84M | $-80.0K | $601.0K | |
| CapEx | $14M | $9M | $8M | $12M | $6M | $5M | $2M | |
| Investing Cash Flow | $148M | $-258M | $68M | $27M | $-108M | $-254M | $8M | |
| Stock Issued | $0 | $290M | $0 | $19M | $150M | $218M | · | |
| Net Stock Activity | $0 | $290M | $0 | $19M | $150M | $218M | · | |
| Financing Cash Flow | $239M | $486M | $3M | $117M | $154M | $339M | $126.0K | |
| Net Change in Cash | $137M | $55M | $-10M | $-15M | $-39M | $85M | $9M | |
| Taxes Paid | · | · | · | · | · | $1.0K | $1.0K | |
| Free Cash Flow | $-263M | $-182M | $-90M | $-172M | $-90M | $-5M | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -340.2% | -390.5% | -201.4% | -476.0% | -396.3% | -364.7% | · | |
| Net Margin | -314.9% | -354.9% | -187.0% | -466.9% | -393.9% | -242.7% | · | |
| Pretax Margin | -314.0% | -354.4% | -187.0% | -466.9% | -393.5% | -357.9% | · | |
| EBITDA Margin | -340.2% | -390.5% | -201.4% | -476.0% | -396.3% | -364.7% | · | |
| ROA | -39.0% | -37.8% | -37.3% | -40.4% | -26.9% | -19.6% | · | |
| ROE | -53.6% | -42.8% | -66.3% | -55.8% | -32.7% | -14.5% | · | |
| ROIC | -53.2% | -40.5% | · | -60.5% | -34.5% | -15.2% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 6.5 | 3.4 | 4.5 | 4.7 | 6.7 | · | |
| Quick Ratio | 2.9 | 1.1 | 0.6 | 4.4 | 4.6 | 6.3 | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | · | · | 12.9 | 9.9 | · | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 53.9% | -29.1% | 99.3% | 29.8% | 67.0% | · | · | |
| Revenue CAGR 3Y | 29.5% | 22.4% | 62.9% | · | · | · | · | |
| Revenue CAGR 5Y | 36.4% | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $84M | $55M | $77M | $39M | $30M | $18M | · | |
| Net Income TTM | $-264M | $-194M | $-144M | $-180M | $-117M | $-43M | · | |
| Market Cap | $1.80B | $1.68B | $303M | $584M | $1.29B | $1.66B | · | |
| P/E | -5.8 | -7.7 | -2.3 | -3.3 | -10.6 | · | · | |
| P/S | 21.4 | 30.8 | 3.9 | 15.1 | 43.3 | 93.0 | · | |
| P/B | 3.3 | 3.2 | 1.5 | 1.9 | 3.8 | 5.7 | · | |
| P / Tangible Book | 3.3 | 3.2 | 1.5 | 1.9 | 3.8 | 5.7 | · | |
| P / Cash Flow | -7.2 | -9.7 | -3.7 | -3.7 | -15.3 | -20705.3 | · | |
| P / FCF | -6.8 | -9.2 | -3.4 | -3.4 | -14.3 | -357.5 | · | |
| Earnings Yield | -17.2% | -13.0% | -42.6% | -29.9% | -9.5% | · | · |
Compte de résultat 13
| Métrique | Tendance | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $14M | $8M | $44M | $18M | $13M | $13M | $12M | $17M | $15M | $18M | $31M | $13M | $7M | $11M | $11M | |
| R&D Expense | $84M | $83M | $86M | $78M | $70M | $67M | $55M | $49M | $50M | $50M | $48M | $46M | $46M | $46M | $48M | $47M | |
| SG&A Expense | $15M | $14M | $13M | $14M | $12M | $11M | $12M | $12M | $12M | $11M | $11M | $12M | $10M | $9M | $10M | $10M | |
| Operating Expenses | $99M | $97M | $99M | $92M | $81M | $78M | $67M | $61M | $62M | $60M | $58M | $57M | $56M | $55M | $58M | $57M | |
| Operating Income | $-92M | $-83M | $-91M | $-48M | $-63M | $-65M | $-55M | $-49M | $-45M | $-45M | $-40M | $-27M | $-43M | $-49M | $-47M | $-46M | |
| Pretax Income | · | $-78M | $-86M | $-43M | $-56M | $-59M | $-49M | $-44M | $-41M | $-42M | $-37M | $-24M | $-41M | $-47M | $-46M | $-45M | |
| Income Tax | $0 | $0 | $0 | $760.0K | $0 | $8.0K | $82.0K | $90.0K | $90.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-87M | $-78M | $-86M | $-43M | $-56M | $-59M | $-49M | $-45M | $-42M | $-42M | $-37M | $-24M | $-41M | $-47M | $-46M | $-45M | |
| EPS (Basic) | $-0.79 | $-0.83 | $-1.03 | $-0.52 | $-0.67 | $-0.74 | $-0.67 | $-0.71 | $-0.76 | $-0.77 | $-0.68 | $-0.45 | $-0.75 | $-0.85 | $-0.90 | $-1.01 | |
| EPS (Diluted) | $-0.79 | $-0.83 | $-1.03 | $-0.52 | $-0.67 | $-0.74 | $-0.67 | $-0.71 | $-0.76 | $-0.77 | $-0.68 | $-0.45 | $-0.75 | $-0.85 | $-0.90 | $-1.01 | |
| Shares (Basic) | 110,071,668 | -164,935,701 | 84,159,336 | 83,882,477 | 83,560,795 | -122,940,073 | 72,779,381 | 62,377,551 | 54,903,407 | -108,340,241 | 54,390,859 | 54,259,045 | 54,028,238 | -91,852,773 | 50,868,542 | 44,898,409 | |
| Shares (Diluted) | 110,071,668 | -164,935,701 | 84,159,336 | 83,882,477 | 83,560,795 | -122,940,073 | 72,779,381 | 62,377,551 | 54,903,407 | -108,340,241 | 54,390,859 | 54,259,045 | 54,028,238 | -91,852,773 | 50,868,542 | 44,898,409 | |
| EBITDA | $-92M | · | $-91M | $-48M | $-63M | · | $-55M | $-49M | $-45M | · | $-40M | $-27M | $-43M | · | $-47M | $-46M |
Bilan 20
| Métrique | Tendance | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $71M | $247M | $78M | $84M | $76M | $110M | $99M | $117M | $50M | $55M | $42M | $59M | $34M | $64M | $48M | $42M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | $217M | $222M | $244M | · | $297M | $256M | |
| Receivables | · | · | · | $19M | · | · | · | · | · | · | $2M | · | · | · | · | · | |
| Prepaid Expense | $14M | $14M | $12M | $11M | $14M | $10M | $8M | $7M | $7M | · | $7M | $9M | $11M | · | $10M | $10M | |
| Current Assets | $554M | $607M | $441M | $515M | $564M | $619M | $456M | $450M | $251M | · | $268M | $290M | $288M | · | $355M | $307M | |
| PP&E (Net) | $22M | $22M | $20M | $19M | $18M | $18M | $17M | $19M | $18M | · | $17M | $18M | $18M | · | $17M | $16M | |
| PP&E (Gross) | $61M | $60M | $61M | $57M | $55M | $52M | $49M | $48M | $46M | · | $42M | $42M | $39M | · | $35M | $32M | |
| Accum. Depreciation | $40M | $38M | $41M | $39M | $37M | $35M | $32M | $30M | $28M | · | $25M | $23M | $21M | · | $18M | $17M | |
| Other Non-current Assets | $7M | $7M | $7M | $6M | $6M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $4M | $4M | |
| Total Assets | $636M | $688M | $522M | $592M | $615M | $669M | $514M | $511M | $313M | · | $308M | $351M | $370M | · | $459M | $394M | |
| Accounts Payable | $10M | $11M | $9M | $6M | $8M | $11M | $4M | $3M | $6M | · | $2M | $5M | $6M | · | $6M | $6M | |
| Current Liabilities | $92M | $86M | $82M | $76M | $90M | $96M | $86M | $81M | $88M | · | $61M | $72M | $65M | · | $68M | $73M | |
| Capital Leases | $55M | $53M | $53M | $47M | $20M | $20M | $21M | $21M | $22M | · | $3M | $4M | $5M | · | $8M | $9M | |
| Total Liabilities | $155M | $149M | $150M | $144M | $134M | $142M | $137M | $140M | $144M | · | $74M | $91M | $96M | · | $117M | $128M | |
| Common Stock | $103.0K | $102.0K | $77.0K | $76.0K | $76.0K | $76.0K | $67.0K | $64.0K | $49.0K | · | $49.0K | $48.0K | $47.0K | · | $47.0K | $45.0K | |
| Retained Earnings | $-1.09B | $-1.00B | $-925M | $-839M | $-795M | $-739M | $-680M | $-631M | $-587M | · | $-503M | $-466M | $-442M | · | $-355M | $-309M | |
| AOCI | $56.0K | $105.0K | $119.0K | $-20.0K | $226.0K | $150.0K | $344.0K | $-135.0K | $-350.0K | · | $-1M | $-2M | $-3M | · | $-4M | $-3M | |
| Stockholders' Equity | $481M | $539M | $372M | $448M | $481M | $527M | $377M | $371M | $169M | $200M | $234M | $260M | $274M | $304M | $343M | $267M | |
| Liabilities + Equity | $636M | $688M | $522M | $592M | $615M | $669M | $514M | $511M | $313M | · | $308M | $351M | $370M | · | $459M | $394M | |
| Shares Outstanding | 103,399,813 | 101,807,484 | 76,872,686 | 76,433,664 | 76,234,799 | 75,870,718 | 67,083,523 | 64,356,535 | 49,136,954 | · | 48,503,768 | 47,631,208 | 47,444,853 | · | 47,147,781 | 45,040,068 |
Flux de trésorerie 10
| Métrique | Tendance | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $9M | $9M | $10M | $10M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $9M | $8M | $8M | $7M | $7M | |
| Operating Cash Flow | $-72M | $-68M | $-57M | $-63M | $-61M | $-49M | $-42M | $-40M | $-42M | $27M | $-41M | $-18M | $-48M | $-38M | $-46M | $-33M | |
| CapEx | $1M | $5M | $3M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $1M | $2M | $3M | $3M | $3M | |
| Investing Cash Flow | $-124M | $346.0K | $50M | $71M | $26M | $-141M | $-21M | $-131M | $36M | $-14M | $23M | $44M | $16M | $55M | $-63M | $-5M | |
| Stock Issued | $18M | $0 | $0 | · | $0 | $199M | $42M | · | · | $0 | $0 | · | · | $0 | · | · | |
| Net Stock Activity | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $20M | $236M | $1M | $6.0K | $1M | $201M | $46M | $238M | $2M | $7.0K | $2M | $25.0K | $1M | $-135.0K | $115M | $432.0K | |
| Net Change in Cash | $-176M | $169M | $-6M | $8M | $-34M | $11M | $-18M | $67M | $-5M | $12M | $-17M | $25M | $-31M | $17M | $6M | $-37M | |
| Free Cash Flow | $-73M | · | · | · | $-65M | · | · | · | $-45M | · | · | · | $-51M | · | · | · |
Rentabilité 7
| Métrique | Tendance | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1479.4% | · | -1157.6% | -109.7% | -340.7% | · | -433.8% | -401.4% | -272.7% | · | -216.7% | -87.2% | -338.6% | · | -432.9% | -399.9% | |
| Net Margin | -1394.3% | · | -1094.8% | -98.7% | -305.4% | · | -388.9% | -368.4% | -250.3% | · | -200.3% | -79.1% | -321.1% | · | -423.6% | -397.1% | |
| Pretax Margin | · | · | -1094.8% | -96.9% | -305.4% | · | -388.3% | -367.6% | -249.8% | · | · | · | · | · | -423.6% | -397.1% | |
| EBITDA Margin | -1479.4% | · | -1157.6% | -109.7% | -340.7% | · | -433.8% | -401.4% | -272.7% | · | -216.7% | -87.2% | -338.6% | · | -432.9% | -399.9% | |
| ROA | · | · | -16.7% | -7.9% | -12.2% | · | -11.9% | -10.3% | -12.2% | · | -9.6% | -6.5% | -10.1% | · | -9.6% | -10.0% | |
| ROE | · | · | -23.1% | -10.6% | -17.3% | · | -16.0% | -14.1% | -18.8% | · | -12.8% | -9.2% | -14.1% | · | -12.7% | -13.7% | |
| ROIC | · | · | -24.6% | -11.0% | -13.1% | · | -14.5% | -13.1% | -26.9% | · | · | · | · | · | -13.6% | -17.1% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 5.4 | 6.8 | 6.3 | · | 5.3 | 5.6 | 2.9 | · | 4.4 | 4.0 | 4.4 | · | 5.3 | 4.2 | |
| Quick Ratio | · | · | 1.0 | 1.4 | 0.8 | · | 1.1 | 1.4 | 0.6 | · | 4.2 | 3.9 | 4.3 | · | 5.1 | 4.1 |
Efficacité 2
| Métrique | Tendance | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | 4.1 | · | · | · | · | · | · | 18.5 | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $77M | · | · | $94M | $62M | · | $60M | $78M | $78M | · | $73M | $66M | $45M | · | $42M | $38M | |
| Net Income TTM | $-273M | · | · | $-205M | $-206M | · | $-172M | $-147M | $-144M | · | $-148M | $-156M | $-174M | · | $-162M | $-143M | |
| Market Cap | · | · | $718M | $812M | $1.18B | · | $1.69B | $1.01B | $607M | · | $412M | $482M | $447M | · | $742M | $454M | |
| P/E | -5.3 | · | · | -4.2 | -5.7 | · | -8.9 | -6.1 | -4.7 | · | -3.1 | -3.3 | -2.6 | · | -4.5 | -3.1 | |
| P/S | · | · | · | 8.7 | 19.1 | · | 28.3 | 13.0 | 7.7 | · | 5.7 | 7.3 | 10.0 | · | 17.6 | 11.8 | |
| P/B | · | · | 1.9 | 1.8 | 2.4 | · | 4.5 | 2.7 | 3.6 | · | 1.8 | 1.9 | 1.6 | · | 2.2 | 1.7 | |
| P / Tangible Book | · | · | 1.9 | 1.8 | 2.4 | · | 4.5 | 2.7 | 3.6 | · | 1.8 | 1.9 | 1.6 | · | 2.2 | 1.7 | |
| P / Cash Flow | · | · | · | · | -19.3 | · | · | · | -14.5 | · | · | · | -9.2 | · | · | · | |
| P / FCF | · | · | · | · | -18.2 | · | · | · | -13.5 | · | · | · | -8.8 | · | · | · | |
| Earnings Yield | -18.9% | · | · | -23.8% | -17.6% | · | -11.2% | -16.5% | -21.4% | · | -32.7% | -30.7% | -38.3% | · | -22.3% | -31.8% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 | 2021-11-30 | |
|---|---|---|---|---|---|
| Revenu | $84M | $55M | $77M | $39M | $30M |
| Marge d'exploitation % | -340.2% | -390.5% | -201.4% | -476.0% | -396.3% |
| Résultat net | $-264M | $-194M | $-144M | $-180M | $-117M |
| BPA dilué | $-3.05 | $-2.88 | $-2.65 | $-3.71 | $-2.73 |
Bilan
| 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 | 2021-11-30 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 7.0 | 6.5 | 3.4 | 4.5 | 4.7 |
| Ratio de liquidité réduite | 2.9 | 1.1 | 0.6 | 4.4 | 4.6 |
Flux de trésorerie
| 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 | 2021-11-30 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-263M | $-182M | $-90M | $-172M | $-90M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.